Deva Holding A.S.
DEVA
Rank in Stocks
#14558
Deva Holding A.S. is a Turkish pharmaceutical firm specializing in the... Deva Holding A.S. is a Turkish pharmaceutical firm specializing in the development and distribution of a wide array of medicinal goods. Its extensive portfolio encompasses treatments for various conditions, including cancer (antineoplastic agents), immune system disorders (immunomodulating agents), skin ailments (dermatological products), hormonal imbalances (systemic hormonal preparations), and infectious or parasitic diseases (anti-infective and antiparasitic products for systemic use). Additionally, the company offers dietary supplements and electrolyte solutions. Deva Holding also supplies pharmaceuticals targeting major bodily systems such as the urogenital and reproductive systems, blood and hematopoietic organs, the cardiovascular system, musculoskeletal system, nervous system, digestive tract and metabolism, respiratory system, and sensory organs. Furthermore, its offerings include specific drug classes like cephalosporins and penicillin, inhalation therapies, both solid and liquid oncological preparations, and veterinary pharmaceuticals. It also produces active pharmaceutical ingredients (APIs), various sterile dosage forms such as ampoules, liquid and lyophilized vials, and ophthalmic drops, alongside medical ampoules for sterile injectables; cologne is also part of its product line. Beyond its domestic operations, Deva Holding exports its products to approximately 60 nations globally. Established in 1958, the company maintains its headquarters in Istanbul, Turkey, and operates as a subsidiary of Eastpharma S.Γ R.L.
Share Price
$1.58
Last synced: 2026-11-09
Market Cap
$316.26M
Change (1 day)
-1.47%
Change (1 year)
6.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Deva Holding A.S. (DEVA)
Category
Healthcare
Revenue for Deva Holding A.S. (DEVA)
Revenue in Jun 2026 TTM: $439.09M
According to Deva Holding A.S.'s latest financial reports, its current revenue (TTM) is $439.09M. In 2025 the company's revenue was $448.03M, an increase over its 2024 revenue of $437.55M. Revenue is the total income a company makes from selling goods or services; unlike earnings, no expenses are subtracted.
Revenue history for Deva Holding A.S. from 2005 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $439.09M | -2.00% |
| 2025 | $448.03M | 2.40% |
| 2024 | $437.55M | 13.41% |
| 2023 | $385.83M | 61.00% |
| 2022 | $239.64M | 36.99% |
| 2021 | $174.94M | -30.16% |
| 2020 | $250.49M | 8.45% |
| 2019 | $230.97M | 17.00% |
| 2018 | $197.42M | -6.68% |
| 2017 | $211.55M | 8.34% |
| 2016 | $195.26M | -1.18% |
| 2015 | $197.60M | -1.49% |
| 2014 | $200.60M | 2.93% |
| 2013 | $194.89M | -17.05% |
| 2012 | $234.95M | 9.64% |
| 2011 | $214.29M | -14.14% |
| 2010 | $249.59M | 12.49% |
| 2009 | $221.89M | 57.35% |
| 2008 | $141.01M | -38.40% |
| 2007 | $228.92M | 78.24% |
| 2006 | $128.43M | -24.73% |
| 2005 | $170.63M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $23.37B | 5,222.49% |
DE
|
|
| $23.57B | 5,267.63% |
DE
|
|
| $29.72B | 6,668.95% |
JP
|
|
| $5.85B | 1,232.00% |
CH
|
|
| $17.41B | 3,865.72% |
IL
|
Questions about Deva Holding A.S.'s revenue
What is Deva Holding A.S.'s revenue?
Deva Holding A.S.'s revenue over the last twelve months is $439.09M, as of Jun 2026.
What was Deva Holding A.S.'s revenue in 2025?
In 2025, Deva Holding A.S.'s revenue was $448.03M, 2.40% more than in 2024 ($437.55M).
How has Deva Holding A.S.'s revenue changed since 2020?
From 2020 to 2025, Deva Holding A.S.'s revenue went from $250.49M to $448.03M, an average growth of 12.33% a year.
How does Deva Holding A.S.'s revenue compare with similar companies?
Deva Holding A.S.'s revenue ($439.09M) is lower than that of all 5 similar companies listed above. The highest among them is Takeda Pharmaceutical Company Limited, with $29.72B.